Scholars Central

Editor

Jay Margolis

Department of Life Sciences, University of Truven Health Analytics, USA

About

As published by the journal they serve.

Dr. Jay Margolis’ career spans over 3 decades as a practicing healthcare professional, specializing in health outcomes research, clinical pharmacotherapy practice, and healthcare informatics. His health outcomes research projects have involved ‘real-world’ data analyses and managed care research, with recent studies focusing in pain, oncology, gastrointestinal, musculoskeletal, neurological, endocrine, and cardiovascular disorders, resulting in numerous posters, presentations, and publications. Dr. Margolis has held leadership and research positions with Truven Health Analytics, HealthCare and IMS Health where he led projects in outcomes research, primary research with patients and physicians including medical chart reviews, and market research for pharmaceutical industry clients. He previously held clinical and leadership positions in institutional pharmacy practice and healthcare informatics as a recognized expert in medical management and clinical pharmacy practice management software. He is an active member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the Academy of Managed Care Pharmacy (AMCP).

Research interests

  • Pain Include Neuropathic pain
  • Sensory Hypersensitivity pain
  • Cluster Headache
  • Health outcomes research
  • Pharmacotherapy
  • Pharmacoeconomics
  • Pharmacoepidemiology and Comparative effectiveness

Journals they serve

The seats these journals name them in.

Articles we hold

Articles in the journals they serve whose byline carries this name.

No article in our collection carries this name on its byline. Not every article names its authors in a way that can be matched, so this is not a list of everything they have written.

This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.